Website
Ratings & Metrics
Financial Documents
| Entity | Document Type | Tax ID |
|---|---|---|
| The Population Council | IRS Form 990 | 13-1687001 |
| The Population Council | Audited Consolidated Financial Statements | multiple |
|
Entity: The Population Council Document Type: IRS Form 990 Tax ID: 13-1687001 |
|
Entity: The Population Council Document Type: Audited Consolidated Financial Statements Tax ID: multiple |
Governance & Transparency
Top Salaries
| Name | Title | Compensation | |
|---|---|---|---|
| 1 | Julia Bunting Thring | President | $475,630 |
| 2 | James E. Sailer | VP/Executive Director, Center for Biomedical Research | $378,366 |
| 3 | Annabel Erulkar | Senior Associate/Country Director | $343,919 |
|
1 Name: Julia Bunting Thring Title: President Compensation: $475,630 |
|
2 Name: James E. Sailer Title: VP/Executive Director, Center for Biomedical Research Compensation: $378,366 |
|
3 Name: Annabel Erulkar Title: Senior Associate/Country Director Compensation: $343,919 |
Analysts' Notes
According to The Population Council consolidated audit of December 31, 2021 (Note 2(k), Concentration of Support): "During 2021 and 2020, approximately $7.6 million and $10.8 million, respectively, of the Council's grants were funded directly by the United States Agency for International Development (USAID)... "The three largest funding sources, one U.S. government agency, one foreign agency and one private foundation, constitute 42% of the revenue in both 2021 and 2020, respectively." |
According to The Population Council consolidated audit of December 31, 2021 (Note 16, Deferred Revenue): "The Population Council was granted $2,000,000 and $4,181,900 under the Paycheck Protection Program 'PPP' administered by a Small Business Administration (SBA) approved partner in 2021 and 2020, respectively. The loans are uncollateralized and are fully guaranteed by the Federal government. As of December 31, 2021, the $2 million received through the PPP2 program is recorded as deferred revenue in accordance with guidance for conditional contributions. The Population Council has identified associated eligible expenses incurred in 2021 during the covered period. The Council expects to file its forgiveness application within the 10-month statutory limit. "In 2021 the Council received from [the] SBA a Notice of Payment [sic] Protection Program Forgiveness Payment for a full amount of the PPP1 loan. Based on that Notice, the $4,181,990 [sic] loan received in 2020 was recognized within grants and contributions revenue in the 2021 [audited] consolidated statement of activities." |
According to The Population Council consolidated audit of December 31, 2021 (Note 17, Commitments and Contingencies): "On March 11, 2020 the World Health Organization declared the novel strain of coronavirus (COVID 19) a global pandemic. The full impact of the COVID 19 pandemic is continuing to evolve as of the date of this report [July 11, 2022]. As a result of the pandemic the Council's offices are still operating either fully remote, or in a hybrid mode, depending on the situation in each particular country. This is slowing down the Council's programs' implementation and, in turn, affects the revenue numbers. There are still many uncertainties associated with the pandemic, including the effect on the awarding organization which funds our programs." |
According to The Population Council consolidated audit of December 31, 2021 (Note 18, Subsequent Events): "On March 1, 2022 the Board of Trustees authorized management to enter into an Asset Purchase/Funding Agreement with the 'International Partnership for Microbicides, Inc.' (IPM) and delegate to the Executive Committee oversight and approval of it. Under the terms of the proposed agreement, the Council will obtain the majority of IPM's assets and liabilities. The agreement is expected to be executed in Q3 2022. "The Council evaluated subsequent events from the consolidated balance sheet date of December 31, 2021 through July 11, 2022, which was the date the [audited] consolidated financial statements were available to be issued and determined that no additional disclosures are required." |